Ten Years of Experience with First-Trimester Screening for Fetal Aneuploidy Employing Biochemistry from Gestational Weeks 6+0 to 13+6

Publisher： Karger

E-ISSN： 1421-9964|37|1|51-57

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.37, Iss.1, 2014-08, pp. : 51-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Procedure-Related Fetal Loss following Chorionic Villus Sampling after First-Trimester Aneuploidy Screening

By  

Fetal Diagnosis and Therapy, Vol. 41, Iss. 3, 2016-07 ,pp. : 184-190

Karger

Access to resources Recommend Favorite

Impact of First-Trimester Aneuploidy Screening in a High-Risk Population

By  

Fetal Diagnosis and Therapy, Vol. 26, Iss. 1, 2009-10 ,pp. : 29-34

Karger

Access to resources Recommend Favorite

First-Trimester Screening for Gestational Diabetes Mellitus Based on Maternal Characteristics and History

By  

Fetal Diagnosis and Therapy, Vol. 38, Iss. 1, 2014-12 ,pp. : 14-21

Karger

Access to resources Recommend Favorite

First-Trimester Placental Growth Factor in Screening for Gestational Diabetes

By  

Fetal Diagnosis and Therapy, Vol. 39, Iss. 4, 2015-10 ,pp. : 287-291

Karger

Access to resources Recommend Favorite

Screening for Trisomy 21 with Maternal Age, Fetal Nuchal Translucency and Maternal Serum Biochemistry at 11–14 Weeks: A Regional Experience from Germany

By  

Fetal Diagnosis and Therapy, Vol. 21, Iss. 3, 2006-04 ,pp. : 264-268

Karger

Access to resources Recommend Favorite